Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
26.11
+1.02 (4.07%)
Mar 27, 2026, 4:00 PM EDT

SHA:688443 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,5749,9889,20014,649--
Market Cap Growth
4.78%8.57%-37.20%---
Enterprise Value
8,3058,7207,40512,246--
Last Close Price
26.1127.2425.0939.95--
PS Ratio
41.5043.29305.7012091.50--
PB Ratio
5.365.594.335.26--
P/TBV Ratio
5.495.724.425.35--
EV/Sales Ratio
36.0037.79246.0410108.38--
Debt / Equity Ratio
0.590.590.390.2326.891.83
Net Debt / Equity Ratio
-0.71-0.71-0.76-0.8217.030.42
Net Debt / EBITDA Ratio
2.682.682.053.05-0.87-0.48
Net Debt / FCF Ratio
--2.604.86-1.53-0.37
Asset Turnover
--0.010.0000.05
Inventory Turnover
--0.11-0.040.80
Quick Ratio
--14.1221.332.275.15
Current Ratio
--15.0522.153.166.15
Return on Equity (ROE)
-27.40%-27.40%-32.47%-56.97%-337.99%-
Return on Assets (ROA)
---15.62%-21.82%-38.85%-25.14%
Return on Capital Employed (ROCE)
---28.30%-23.00%-73.10%-32.90%
Earnings Yield
-5.60%-5.37%-8.67%-5.47%--
FCF Yield
---6.75%-3.20%--
Buyback Yield / Dilution
0.72%0.72%-14.63%-16.79%0.32%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.